NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: DELL 21.57%
Why Dell Stock Surged Today
NASDAQ: PSKY 24.52%
Warner Bros Discovery Deal: Why Netflix May Have Still Won
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: NGNE 77.39%
NASDAQ: KORE 77.39%
NASDAQ: ACXIF 77.39%
NASDAQ: DELL 77.39%
NASDAQ: PSKY 77.39%
